Ledger.Open graph →

SEC Form D · filed May 5, 2023

Antiva Biosciences, Inc

Offering

$53.0M

Sold

$26.6M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

BRISBANE, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Oranee Daniels · BRISBANE, CAExec Wende Hutton · BRISBANE, CADirector Gail Maderis · BRISBANE, CADirector Jenny Yip · BRISBANE, CADirector Raju Gadiraju · BRISBANE, CAExec Sarah Walter · BRISBANE, CAExec Clifford Samuel · BRISBANE, CADirector Kristine Ball · BRISBANE, CAExec · Director Florencia Segal · BRISBANE, CADirector Dimitre Kirilov · Bensenville, ILDirector Jefferson W. Kirby · Morristown, NJExec John Cozzi · NEW YORK, NYDirector Kenneth J. Burns · NEW YORK, NYDirector J. W. Kirby, Jr · Morristown, NJExec Same Broadfield Capital, LLC · Morristown, NJExec Same Broadfield Capital Management, LLC · Morristown, NJDirector Brian Goodman · Cambridge, MADirector Brad R. Banks · CAMBRIDGE, MADirector Camilo R. Cepeda · CAMBRIDGE, MADirector William C. Collin · Richmond, VAExec Charles C. Wills · Richmond, VAExec John C. Eckstein · Richmond, VAExec James C. Rose, Jr · Richmond, VADirector Jason Lieber · Woodmere, NYDirector Kristine Ball · BRISBANE, CAExec · Director Brian Goodman · Cambridge, MADirector Florencia Segal · BRISBANE, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗